Close Close
Sign In
Newsletters
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
Podcast Center Video Center Webcasts Resource Center Events
About ThinkAdvisor Contact Us Advertise With Us Asset & Logo Licensing Sitemap Terms of Service Privacy Policy Copyright © 2024 ALM Global, LLC. All Rights Reserved.
ThinkAdvisor

Life Health > Health Insurance

HMO Copays Continue Upward

By Staff Writer

X
Your article was successfully shared with the contacts you provided.

NU Online News Service, June 19, 10:45 a.m. – Health Industries Research Companies, Santa Cruz, Calif., says health maintenance organizations are rapidly adopting the “three-tier copay” system for encouraging HMO members to use generic drugs and brand-name drugs on the HMOs’ preferred drug lists.

Three-tier copay programs now cover about 35% of HMO members, Health Industries says.

The proportion will rise to more than 47% of all beneficiaries by year-end 2002, Health Industries predicts.

HMOs and other health plans that use three-tier copay programs usually charge low out-of-pocket fees for members who buy generic drugs; slightly higher fees for members who buy brand-name drugs on the preferred drug lists; and high fees for members who buy brand-name drugs that are not on the preferred drug lists.

Copay levels have increased steadily in most sectors during the last year.

Health Industries predicts average out-of-pocket costs will approach $10 for the first tier, $25 for the second tier and $40 for the the third tier within the next twelve months.

The average difference in the copay fee for a brand-name drug on the HMO’s preferred drug list and other brand-name drugs has also increased.

The average penalty for buying brand-name drugs off the preferred list, rather than brand-name drugs on the preferred list, was $10.15 in 1999, $14.85 in 2000, and $16.25 in 2001, Health Industries says.

HMOs and employers are also experimenting with three-tier percentage copays that require consumers to pay a fixed percentage of drug costs, Health Industries says.

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.